Takahari, Daisuke Shinozaki, Eiji Wakatsuki, Takeru Ooki, Akira Ozaka, Masato Suzuki, Takeshi Nakayama, Izuma Osumi, Hiroki Kamiimabeppu, Daisaku Sato, Taro
...
Published in
International Journal of Clinical Oncology
Coronavirus disease 2019 (COVID-19) was declared to be a global pandemic by the World Health Organization on March 11, 2020. On April 7, 2020, a state of emergency was declared in Japan, as had been by other nations worldwide. This unprecedented crisis has profound implications for patients undergoing chemotherapy and for practicing healthcare prof...
Mori, Keiichiro Mostafaei, Hadi Pradere, Benjamin Motlagh, Reza Sari Quhal, Fahad Laukhtina, Ekaterina Schuettfort, Victor M. Abufaraj, Mohammad Karakiewicz, Pierre I. Kimura, Takahiro
...
Published in
International Journal of Clinical Oncology
Management of non-metastatic castration-resistant prostate cancer (nmCRPC) has undergone a paradigm shift with next-generation androgen receptor inhibitors. However, direct comparative data are not available to inform treatment decisions and/or guideline recommendations. Therefore, we performed network meta-analysis to indirectly compare the effica...
Kusada, Takeaki Toita, Takafumi Ariga, Takuro Kudaka, Wataru Maemoto, Hitoshi Makino, Wataru Ishikawa, Kazuki Heianna, Joichi Nagai, Yutaka Aoki, Yoichi
...
Published in
International Journal of Clinical Oncology
Background This prospective study investigated the feasibility, toxicity, and oncologic outcomes of definitive radiotherapy (RT) consisting of whole pelvic radiotherapy with no central shielding (noCS-WPRT) and CT-based intracavitary brachytherapy (ICBT) in Japanese patients with cervical cancer. Methods Patients with cervical cancer of FIGO stages...
Teshima, Yasutomo Kizaki, Minako Kurihara, Ryohei Kano, Ryosuke Harumiya, Miki
Published in
International Journal of Clinical Oncology
Purpose To investigate the safety and efficacy of dabrafenib and trametinib combination therapy for BRAF V600 mutation-positive unresectable and metastatic melanoma in over 100 Japanese patients of a real-world clinical setting. Patients The surveillance period of interim post-marketing surveillance (PMS) analysis was from June 2016 to November 201...
Miura, Noriyoshi Mori, Keiichiro Mostafaei, Hadi Quhal, Fahad Sari Motlagh, Reza Abufaraj, Mohammad Pradere, Benjamin Aydh, Abdulmajeed Laukhtina, Ekaterina D’Andrea, David
...
Published in
International Journal of Clinical Oncology
Introduction This systematic review and meta-analysis aimed to assess the prognostic value of testosterone in patients with castration-resistant prostate cancer (CRPC). Materials and methods PubMed, Web of Science, and Scopus databases were systematically searched until December 2019, according to the Preferred Reporting Items for Systemic Review a...
Nakano, Shintaro Yuki, Satoshi Kawamoto, Yasuyuki Nakatsumi, Hiroshi Ando, Takayuki Kajiura, Shinya Yoshikawa, Ayumu Harada, Kazuaki Hatanaka, Kazuteru Tanimoto, Aya
...
Published in
International Journal of Clinical Oncology
Background It is unclear whether the UGT1A1 status, single heterozygous (SH) or wild type (WT), is associated with the efficacy and toxicity of irinotecan monotherapy in advanced gastric cancer (AGC). We investigated the association between clinical outcomes (efficacy and safety) and UGT1A1 status in patients who received irinotecan monotherapy. Me...
Ishida, Kazuhisa Nakashima, Takayuki Shibata, Toshiyuki Hara, Akira Tomita, Hiroyuki
Published in
International Journal of Clinical Oncology
DEK is a highly conserved nuclear factor that plays an important role in the regulation of multiple cellular processes. DEK was discovered to be an oncogene as a fusion with NUP214 gene, which results in producing DEK-NUP214 proteins, in a subset of patients with acute myeloid leukemia. Subsequently, DEK overexpression was reported in many cancers,...
Aznab, Mozaffar
Published in
International Journal of Clinical Oncology
Background The aim of this study was investigation of COVID-19 disease and its outcome in cancer patients who needed treatment, in a 90-day period. Methods Cancer patient who required treatment, were evaluated for potential COVID-19 infection in a 90-day period, starting from beginning of this epidemic in Iran, January, to April 19, 2020. For treat...
Wagner, Adam P. Carroll, Cliodhna White, Simon R. Watson, Peter Spoudeas, Helen A. Hawkins, Michael M. Walker, David A. Clare, Isabel C. H. Holland, Anthony J. Ring, Howard
...
Published in
International Journal of Clinical Oncology
Purpose Posterior fossa brain tumours (PFT) and their treatment in young children are often associated with subsequent cognitive impairment. However, reported follow-up periods rarely exceed 10 years. This study reports very long-term cognitive consequences of surviving an early childhood PFT. Methods 62 adult survivors of a PFT, ascertained from a...
Evans, Andy Petty, Russell Macaskill, Jane
Published in
International Journal of Clinical Oncology
Background Our aim is to assess whether the poor breast cancer specific survival (BCSS) seen in women with breast cancer and impaired renal function can be explained by associations with other prognostic factors. Methods The study group was a consecutive series of patients undergoing breast ultrasound (US) who had invasive breast cancer ( n = 1171)...
